Mostrar el registro sencillo del ítem
dc.contributor.author | Murtada, S-, I. | es_ES |
dc.contributor.author | Kawamura, Y. | es_ES |
dc.contributor.author | Caulk, A. W. | es_ES |
dc.contributor.author | Ahmadzadeh, H. | es_ES |
dc.contributor.author | Mikush, N. | es_ES |
dc.contributor.author | Zimmerman, K. | es_ES |
dc.contributor.author | Kavanagh, D. | es_ES |
dc.contributor.author | Weiss, D. | es_ES |
dc.contributor.author | Latorre, Marcos | es_ES |
dc.contributor.author | Zhuang, Z. W. | es_ES |
dc.contributor.author | Shadel, G. S. | es_ES |
dc.contributor.author | Braddock, D. T. | es_ES |
dc.contributor.author | Humphrey, Jay D. | es_ES |
dc.date.accessioned | 2023-01-26T19:01:33Z | |
dc.date.available | 2023-01-26T19:01:33Z | |
dc.date.issued | 2020-05-27 | es_ES |
dc.identifier.issn | 1742-5689 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10251/191467 | |
dc.description.abstract | [EN] Hutchinson-Gilford progeria syndrome (HGPS) is an ultra-rare disorder with devastating sequelae resulting in early death, presently thought to stem primarily from cardiovascular events. We analyse novel longitudinal cardiovascular data from a mouse model of HGPS (Lmna(G609G/G609G)) using allometric scaling, biomechanical phenotyping, and advanced computational modelling and show that late-stage diastolic dysfunction, with preserved systolic function, emerges with an increase in the pulse wave velocity and an associated loss of aortic function, independent of sex. Specifically, there is a dramatic late-stage loss of smooth muscle function and cells and an excessive accumulation of proteoglycans along the aorta, which result in a loss of biomechanical function (contractility and elastic energy storage) and a marked structural stiffening despite a distinctly low intrinsic material stiffness that is consistent with the lack of functional lamin A. Importantly, the vascular function appears to arise normally from the low-stress environment of development, only to succumb progressively to pressure-related effects of the lamin A mutation and become extreme in the peri-morbid period. Because the dramatic life-threatening aortic phenotype manifests during the last third of life there may be a therapeutic window in maturity that could alleviate concerns with therapies administered during early periods of arterial development. | es_ES |
dc.description.sponsorship | This work was supported, in part, by grants from the US National Institutes of Health: R01 HL105297 (J.D.H.) and P01 HL134605 (Dan Rifkin) and R01 AG047632 and R33 ES025636 (G.S.S.) | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | The Royal Society | es_ES |
dc.relation.ispartof | Journal of The Royal Society Interface | es_ES |
dc.rights | Reconocimiento (by) | es_ES |
dc.subject | Pulse wave velocity | es_ES |
dc.subject | Ageing | es_ES |
dc.subject | Diastolic dysfunction | es_ES |
dc.subject | Progeria | es_ES |
dc.subject | Allometric scaling | es_ES |
dc.subject | Aortic stiffness | es_ES |
dc.title | Paradoxical aortic stiffening and subsequent cardiac dysfunction in Hutchinson-Gilford progeria syndrome | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.1098/rsif.2020.0066 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/NIH//R01 HL105297//Mechanisms Underlying the Progression of Arterial Stiffness in Hypertension/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/NIH//P01 HL134605 //Endothelial Mechanotransduction in Thoracic Aneurysm Formation and Progression/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/NIH//R01 AG047632 //Nuclear Control of Mitochondrial Gene Expression/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/NIH//R33 ES025636//Inducible Mouse Models of Mitochondrial ROS Signaling and Environment Stress/ | es_ES |
dc.rights.accessRights | Abierto | es_ES |
dc.description.bibliographicCitation | Murtada, SI.; Kawamura, Y.; Caulk, AW.; Ahmadzadeh, H.; Mikush, N.; Zimmerman, K.; Kavanagh, D.... (2020). Paradoxical aortic stiffening and subsequent cardiac dysfunction in Hutchinson-Gilford progeria syndrome. Journal of The Royal Society Interface. 17(166):1-12. https://doi.org/10.1098/rsif.2020.0066 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | https://doi.org/10.1098/rsif.2020.0066 | es_ES |
dc.description.upvformatpinicio | 1 | es_ES |
dc.description.upvformatpfin | 12 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 17 | es_ES |
dc.description.issue | 166 | es_ES |
dc.identifier.pmid | 32453981 | es_ES |
dc.identifier.pmcid | PMC7276555 | es_ES |
dc.relation.pasarela | S\472449 | es_ES |
dc.contributor.funder | National Institutes of Health, EEUU | es_ES |
dc.subject.ods | 03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edades | es_ES |